Figure 2 shows boxplots presenting the significantly different ACPA concentration levels of DLBCL patients and the RA cohort: median 10.4 (range from 5.7 to 153.4) versus 124.1 (5.9–200); p = 0.0001. The gene discussed is PRTN3; the disease is rheumatoid arthritis.